Assembly Biosciences Inc (FRA:V7B) Stock News, Headlines & Updates
Assembly Biosciences Inc Stock News from GuruFocus
- 1
Jun 30, 2025
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
Marketwired • 7:00am
Jun 25, 2025
Assembly Biosciences (ASMB) Reports Positive Phase 1b Results for Hepatitis B Treatment | ASMB Stock News
GuruFocus News • 7:31am
Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
Marketwired • 7:00am
May 27, 2025
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
Marketwired • 4:00pm
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference | ASMB Stock News
GuruFocus News • 3:19pm
Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics | ASMB Stock News
GuruFocus News • 6:19am
May 08, 2025
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
Marketwired • 4:00pm
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast
GuruFocus News • 3:54pm
May 07, 2025
Assembly Biosciences (ASMB) Highlights Promising Preclinical Data at EASL Congress | ASMB Stock News
GuruFocus News • 7:51am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news